UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

Annals of surgical oncology, 2020-12, Vol.27 (13), p.4870-4871

Beasley, Georgia M.

2020

Volltextzugriff (PDF)

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

Annals of surgical oncology, 2020-09, Vol.27 (9), p.3121-3122

Beasley, Georgia M.

2020

Volltextzugriff (PDF)

Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1851-1856

2024

Volltextzugriff (PDF)

ASO Author Reflections: It’s About Time?

Annals of surgical oncology, 2023-10, Vol.30 (11), p.6353-6354

2023

Volltextzugriff (PDF)

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Nature communications, 2021-03, Vol.12 (1), p.1858-1858, Article 1858

2021

Volltextzugriff (PDF)

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell reports (Cambridge), 2021-05, Vol.35 (5), p.109071-109071, Article 109071

2021

Volltextzugriff (PDF)

ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma

Annals of surgical oncology, 2021-07, Vol.28 (7), p.3511-3511

2021

Volltextzugriff (PDF)

Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers: Balancing Safety and Efficiency

Annals of surgery, 2015-06, Vol.261 (6), p.1044-1045

2015

Volltextzugriff (PDF)

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

Frontiers in oncology, 2022-10, Vol.12, p.1021057

2022

Volltextzugriff (PDF)

Mind the gap: Gendered publication trends in oncology

Cancer, 2020-06, Vol.126 (12), p.2859-2865

2020

Volltextzugriff (PDF)

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

Frontiers in immunology, 2019-07, Vol.10, p.1767-1767

2019

Volltextzugriff (PDF)

Great Debate: Limb Infusion for Melanoma: A Thing of the Past?

Annals of surgical oncology, 2023-10, Vol.30 (11), p.6319-6324

2023

Volltextzugriff (PDF)

Contrast mechanisms in pump-probe microscopy of melanin

Optics express, 2022-08, Vol.30 (18), p.31852-31862

2022

Volltextzugriff (PDF)

ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy

Annals of surgical oncology, 2020-12, Vol.27 (13), p.5126-5127

2020

Volltextzugriff (PDF)

National Trends in Management of Pathologic Stage III Melanoma

Annals of surgical oncology, 2023-05, Vol.30 (5), p.2586-2589

2023

Volltextzugriff (PDF)

Racial, Ethnic, and Gender Diversity Among Academic Surgical Leaders in the US

JAMA surgery, 2023-12, Vol.158 (12), p.1328

2023

Volltextzugriff (PDF)

Hispanic patients with Merkel cell carcinoma have lower mortality compared to non-Hispanic patients in the National Cancer Database

Journal of the American Academy of Dermatology, 2024-06

2024

Volltextzugriff (PDF)

At the Intersection of Intersectionality: Race and Gender Diversity Among Surgical Faculty and Trainees

Annals of surgery, 2024-01, Vol.279 (1), p.77

2024

Volltextzugriff (PDF)

Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines

Journal of surgical oncology, 2022-01, Vol.125 (1), p.28-33

2022

Volltextzugriff (PDF)

Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?

Annals of surgical oncology, 2021-07, Vol.28 (7), p.3452-3454

2021

Volltextzugriff (PDF)

Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy

Annals of surgical oncology, 2020-12, Vol.27 (13), p.5121-5125

2020

Volltextzugriff (PDF)

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy

Science translational medicine, 2022-11, Vol.14 (672), p.eabq7019

2022

Volltextzugriff (PDF)

Survival and tumor characteristics of patients presenting with single primary versus second primary melanoma lesions

Journal of the American Academy of Dermatology, 2023-05, Vol.88 (5), p.1033-1039

2023

Volltextzugriff (PDF)

The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma

Annals of surgical oncology, 2020, Vol.27 (1), p.35-42

2020

Volltextzugriff (PDF)

Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size

Annals of surgical oncology, 2019-12, Vol.26 (13), p.4633-4641

2019

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(205)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(241)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma

ASO Author Reflections: It’s About Time?

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma

Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers: Balancing Safety and Efficiency

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

Mind the gap: Gendered publication trends in oncology

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

Great Debate: Limb Infusion for Melanoma: A Thing of the Past?

Contrast mechanisms in pump-probe microscopy of melanin

ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy

National Trends in Management of Pathologic Stage III Melanoma

Racial, Ethnic, and Gender Diversity Among Academic Surgical Leaders in the US

Hispanic patients with Merkel cell carcinoma have lower mortality compared to non-Hispanic patients in the National Cancer Database

At the Intersection of Intersectionality: Race and Gender Diversity Among Surgical Faculty and Trainees

Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines

Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?

Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy

Survival and tumor characteristics of patients presenting with single primary versus second primary melanoma lesions

The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma

Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size

Suchergebnisse filtern